CuraGen Corporation clinical trials
Acquired by Celldex Therapeutics, Oct 1, 2009 · source ↗
The registry lists 4 studies whose lead sponsor is CuraGen Corporation. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 13, 2016.
Before and after it joined Celldex Therapeutics
- First submitted before CuraGen Corporation became part of Celldex Therapeutics
- 4
- First submitted after CuraGen Corporation became part of Celldex Therapeutics
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- CuraGen Corporation4 studies
Something wrong with this grouping? Tell us on the Celldex Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Celldex Therapeutics studies →
- A Phase II Controlled Trial of Velafermin for Prevention of Oral MucositisCompletedNCT00323518Phase 2
Sponsor listed in the registry: CuraGen Corporation · First submitted before CuraGen Corporation became part of Celldex Therapeutics
- Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow TransplantCompletedNCT00104065Phase 2
Sponsor listed in the registry: CuraGen Corporation · First submitted before CuraGen Corporation became part of Celldex Therapeutics
- Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast CancerCompletedNCT00704158Phase 1/2
Sponsor listed in the registry: CuraGen Corporation · First submitted before CuraGen Corporation became part of Celldex Therapeutics
- A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV MelanomaCompletedNCT00412828Phase 1/2
Sponsor listed in the registry: CuraGen Corporation · First submitted before CuraGen Corporation became part of Celldex Therapeutics